Bronchoesophageal fistula formation after three courses of nivolumab for carcinoma of unknown primary with a subgroup of lung squamous cell carcinoma

Immune checkpoint inhibitors (ICIs) are widely used in both monotherapy and combination chemotherapy for various types of cancers. Nivolumab is the most popular among ICIs, and the number of adapted malignant diseases for nivolumab is increasing. Bronchoesophageal fistula formation is a serious comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishiyama, Akihiro, Sakaguchi, Hiroyuki, Yanagimura, Naohiro, Suzuki, Chiaki, Otani, Sakiko, Tanimoto, Azusa, Yamashita, Kaname, Takeuchi, Shinji, Ohtsubo, Koushiro, Ikeda, Hiroko, Yano, Seiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768526/
https://www.ncbi.nlm.nih.gov/pubmed/33391772
http://dx.doi.org/10.1093/omcr/omaa116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768526/
https://www.ncbi.nlm.nih.gov/pubmed/33391772
http://dx.doi.org/10.1093/omcr/omaa116

Ejemplares similares